Loading…
21st Century Cancer ALERT (Access to Life-Saving Early detection, Research and Treatment) Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 6,490 other HR bills in the 111th — cohort avg 44d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2011 · fourth_quarter · Medicare/Medicaid
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs with Medicaid, including: S 717 and H.R. 6224; H Con. Res. 34, establishing a budget for the US Government for FY 12; S. 868 and H.R. 1683, the State Flexibility Act (MOE); and matters under construction by the Joint Select Committee on Deficit Reduction.
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · third_quarter · Medicare/Medicaid
Issues relating to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010, and tobacco cessation programs within Medicaid, including: S. 717 and H.R. 6224; H. Con. Res. 34, establishing a budget for the US Government for FY 12; S. 868 and H.R. 1683, the State Flexibility Act (MOE); and matters under consideration by the Joint Select Committee on Deficit Reduction.
Client expense: $1,420,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office
2011 · third_quarter · Medicare/Medicaid
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S. 717 and H.R. 6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12.
Client expense: $320,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Medicare/Medicaid
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12, S.868 and H.R.1683, the State Flexibility Act (MOE).
Client expense: $540,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office
2011 · second_quarter · Medicare/Medicaid
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S. 717 and H.R. 6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12.
Client expense: $420,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · second_quarter · Medicare/Medicaid
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12, S.868 and H.R.1683, the State Flexibility Act (MOE).
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · first_quarter · Medicare/Medicaid
Issues relatred to implementation of changes of Medicare and Medicaid, pursuant to P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S. 717 and H.R. 6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12.
Client expense: $380,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2011 · first_quarter · Medicare/Medicaid
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, H. Con. Res. 34, establishing a budget for the U.S. Government for FY12.
Client expense: $750,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office
2010 · fourth_quarter · Health Issues
H.R. 2366 Cancer Coverage Parity Act of 2009 S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009 S. 717/ H.R. 6224 - 21st Century Cancer ALERT Act H.R. 4732 - Compassionate Access Act of 2010 Essential Health Benefits Package developemnt FY 2011 Appropriations regarding cancer research
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Health Issues
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.717, and H.R.6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, Johanna's Law reauthorization; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).
Client expense: $670,000 · Firm income: Not reported
2010 · fourth_quarter · Medicare/Medicaid
Issues related to implementation of changes to Medicare and Medicaid, pursuant to P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, the 21st Century Cancer ALERT Act.
Client expense: $670,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office
2010 · fourth_quarter · Medical/Disease Research/Clinical Labs
S. 717/H.R. 6224 - 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act S. 755/H.R. 1816 - Ovarian Cancer Biomarker Research Act of 2009; H.R. 2941 - To Reauthorize and Enhance Johanna's Law to Increase Public Awareness and Knowledge with Respect to Gynecologic Cancers.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
2010 · fourth_quarter · Medicare/Medicaid
S. 63 - Medicaid Advanced Practice Nurses and Physician Assistants Access Act of 2009; S. 54/H.R. 2273 - Registered Nursing Staffing Act; Medicare Quality Cancer Care Demonstration; Medicare Hospital Outpatient Supervision Requirements; H.R. 1927 - Assuring and Improving Cancer Treatment Education and Cancer Symptom Management Act; Health Reform; H.R. 2939 - Oncology Care Quality Improvement Act of 2009; Medicare Reimbursement for Cancer Care; S. 1773/H.R. 1844 - Comprehensive Cancer Care Improvement Act; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act; H.R. 4872 - Reconciliation Act of 2010; S. 717/H.R. 6224 - 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act.
Client expense: Not reported · Firm income: $40,000
2010 · third_quarter · Medicare/Medicaid
S. 63 - Medicaid Advanced Practice Nurses and Physician Assistants Access Act of 2009; S. 54/H.R. 2273 - Registered Nursing Staffing Act; Medicare Quality Cancer Care Demonstration; Medicare Hospital Outpatient Supervision Requirements; H.R. 1927 - Assuring and Improving Cancer Treatment Education and Cancer Symptom Management Act; Health Reform; H.R. 2939 - Oncology Care Quality Improvement Act of 2009; Medicare Reimbursement for Cancer Care; S. 1773/H.R. 1844 - Comprehensive Cancer Care Improvement Act; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act; H.R. 4872 - Reconciliation Act of 2010; S. 717/H.R. 6224 - 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act.
Client expense: Not reported · Firm income: $40,000
2010 · third_quarter · Medical/Disease Research/Clinical Labs
S. 717/H.R. 6224 - 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act S. 755/H.R. 1816 - Ovarian Cancer Biomarker Research Act of 2009; H.R. 2941 - Reauthorization of Johanna's Law.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
2010 · fourth_quarter · Medicare/Medicaid
Issues related to health care reform, Medicare and Medicaid, coverage of cancer related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to implementation of Medicare & Medicaid related provisions enacted as Part of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation progrmas within Medicaid, including S. 717 and H.R. 6224, the 21st Century Cancer Alert Act.
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
Issues related to health disparities, health care reform, quality of life, federal helath care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R. 1189 Colorectal Cancer Early Detection, Prevention and Treatment Act; S. 717, and H.R. 6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S. 488, the Access to Cancer Trials Act of 2009; H.R. 1740 and H.R. 5560, the Quality Cancer Care of Life Act of 2010 and the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010.
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
H. R. 2400, Strategies to Address Antimicrobial Resistance (STARR) Act; H. R. 6331, GAIN Act; Issues pertaining to the development of new antibiotics; H. R. 3276, American Medical Isotope Production Act; H. R. 6224, 21st Century ALERT Act; Issues pertaining to the orphan drug exemption to the 340 (B) program.
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
H.R. 2366 Cancer Coverage Parity Act of 2009 S. 488/H.R. 716 - Access to Cancer Clinical Trials Act of 2009 H.RES.1433 - Designation of September 2010 as Blood Cancer Awareness Month S. 717/ H.R. 6224 - 21st Century Cancer ALERT Act S.3697 - Creating Hope Act of 2010
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.717, and H.R.6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).
Client expense: $1,110,000 · Firm income: Not reported
2010 · third_quarter · Medicare/Medicaid
Issues related to health care reform, Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R.2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to implentation of Medicare & Medicaid related provisions enacted as part of P.L.111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R.6224, the 21st Century Cancer ALERT Act.
Client expense: $1,110,000 · Firm income: Not reported
2010 · third_quarter · Health Issues
Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R. 1189 Colorectal Cancer Early Detection, Prevention and Treatment Act; S. 717, and H.R. 6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S. 488, the Access to Cancer Clinical Trials Act of 2009; H.R. 1740 and H.R. 5560, the Quality Cancer Care of Life Act of 2010 and the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
Issues related to health care reform, Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R, 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to implementation of Medicare & Medical realted provisions enacted as part of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S. 717 and H.R. 6224, the 21st Century Cancer ALERT Act.
Client expense: $80,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
Issues related to health care reform, Medicare and Medicaid, coverage of cancer-related services and prevention measures, including H.R. 2291, the Medicare Early Detection of Cancer Promotion Act. Issues relating to implementation of Medicare & Medicaid related provisions enacdted as part of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010. Issues relating to tobacco cessation programs within Medicaid, including S.717 and H.R. 6224, the 21st Century Act.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
S. 63 - Medicaid Advanced Practice Nurses and Physician Assistants Access Act of 2009; S. 54/H.R. 2273 - Registered Nursing Staffing Act; Medicare Quality Cancer Care Demonstration; Medicare Hospital Outpatient Supervision Requirements; H.R. 1927 - Assuring and Improving Cancer Treatment Education and Cancer Symptom Management Act; Health Reform; H.R. 2939 - Oncology Care Quality Improvement Act of 2009; Medicare Reimbursement for Cancer Care; S. 1773/H.R. 1844 - Comprehensive Cancer Care Improvement Act; H.R. 3962 - Affordable Health Care for America Act; H.R. 3590 - Patient Protection and Affordable Care Act; H.R. 4872 - Reconciliation Act of 2010; S. 717/H.R. 6224 - 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act.
Client expense: Not reported · Firm income: $40,000
2010 · third_quarter · Medical/Disease Research/Clinical Labs
S. 717/H.R. 6224 - 21st Century Cancer ALERT (Access to Life-Saving Early Detection, Research and Treatment) Act S. 755/H.R. 1816 - Ovarian Cancer Biomarker Research Act of 2009; H.R. 2941 - Reauthorization of Johanna's Law.
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
2010 · third_quarter · Health Issues
H. R. 2400, Strategies to Address Antimicrobial Resistance (STARR) Act; H. R. 6331, GAIN Act; Issues pertaining to the development of new antibiotics; H. R. 3276, American Medical Isotope Production Act; H. R. 6224, 21st Century ALERT Act; Issues pertaining to the orphan drug exemption to the 340 (B) program; H. R. 6389, issues pertaining to prostate cancer diagnosis and treatment; Issues pertaining to overactive bladder syndrome..
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office